Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Mayo Clin Proc. 2020 Jun;95(6):1195–1205. doi: 10.1016/j.mayocp.2020.01.028

Table 2.

Age-Specific Prevalence of Vascular Disease

Age Decade, yb
Cerebrovascular
Pathologic Evaluation
50–59 60–69 70–79 80–89
All Patients, Prevalence (95% CI)
WMH 5.2 (3.0–7.3) 16.5 (12.4–20.7) 47.5 (38.5–56.6)
Total CMB 7.0 (4.0–10.1) 10.3 (7.3–13.3) 18.8 (14.6–23.1) 34.8 (26.9–42.7)
Deep CMB 0.2 (0.0–0.7) 2.2 (0.7–3.6) 5.2 (2.9–7.5) 8.1 (3.2–13.0)
Lobar CMB 6.6 (3.7–9.6) 8.0 (5.3–10.6) 15.3 (11.4–19.2) 27.3 (20.2–34.3)
Total infarct 2.7 (0.9–4.4) 8.5 (5.8–11.1) 17.3 (13.2–21.4) 39.8 (30.5–49.1)
Lacunar infarct 1.7 (0.3–3.1) 6.7 (4.4–9.0) 11.3 (8.1–14.5) 26.1 (18.3–33.9)
Cortical infarct 0.6 (0.0–1.5) 2.1 (1.0–3.3) 6.0 (3.3–8.6) 18.4 (8.5–28.2)
Men, Prevalence (95% CI)
WMH 4.5 (1.9–7.0) 11.2 (6.8–15.7) 50.0 (37.0–63.1)
Total CMB 8.5 (3.8–13.2) 15.1 (9.9–20.2) 22.3 (16.1–28.6) 37.7 (26.5–49.0)
Deep CMB 0.5 (0.0–1.4) 3.3 (0.5–6.1) 5.4 (2.2–8.6) 6.2 (1.7–10.7)
Lobar CMB 8.5 (3.8–13.2) 12.0 (7.4–16.7) 19.5 (13.6–25.5) 30.5 (20.8–40.3)
Total infarct 4.3 (1.1–7.5) 10.7 (6.8–14.5) 21.3 (15.2–27.3) 46.7 (33.1–60.2)
Lacunar infarct 2.3 (0.0–4.7) 9.1 (5.5–12.8) 16.5 (11.0–22.0) 28.4 (16.3–40.4)
Cortical infarct 1.3 (0.0–3.2) 3.0 (1.0–5.0) 7.1 (3.5–10.7) 27.3 (10.4–44.2)
Women, Prevalence (95% CI)
WMH 5.8 (2.4–9.1) 21.0 (14.3–27.7) 45.1 (32.8–57.4)
Total CMB 5.7 (1.7–9.7) 6.2 (2.9–9.6) 15.9 (10.1–21.7) 32.0 (20.1–43.8)
Deep CMB 1.2 (0.0–2.4) 5.1 (1.8–8.4) 9.9 (1.4–18.4)
Lobar CMB 5.0 (1.2–8.7) 4.5 (1.7–7.2) 11.7 (6.5–17.0) 24.1 (13.5–34.6)
Total infarct 1.2 (0.0–2.8) 6.6 (2.9–10.3) 14.0 (8.3–19.6) 32.8 (21.5–44.0)
Lacunar infarct 1.2 (0.0–2.8) 4.5 (1.6–7.5) 6.9 (3.1–10.7) 28.4 (16.3–40.4)
Cortical infarct 1.4 (0.0–2.8) 5.0 (1.1–8.9) 9.7 (2.5–16.8)
a

Abbreviations: CI= confidence interval; CMB=cerebral microbleed; WMH=white-matter hyperintensity.

b

Dash indicates no data available.